Laurus Investment Counsel’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.1M Sell
86,520
-3,660
-4% -$555K 8.57% 4
2025
Q1
$13.6M Buy
90,180
+11,030
+14% +$1.66M 9.06% 3
2024
Q4
$14.6M Buy
79,150
+7,435
+10% +$1.37M 7.52% 5
2024
Q3
$19.1M Hold
71,715
7.39% 4
2024
Q2
$20.3M Hold
71,715
8.38% 3
2024
Q1
$26.3M Hold
71,715
9.23% 1
2023
Q4
$22.5M Buy
71,715
+100
+0.1% +$31.3K 8.14% 3
2023
Q3
$18.9M Buy
71,615
+1,207
+2% +$319K 7.95% 2
2023
Q2
$19.6M Sell
70,408
-150
-0.2% -$41.8K 7.04% 4
2023
Q1
$19.3M Buy
70,558
+555
+0.8% +$152K 6.88% 4
2022
Q4
$20.7M Sell
70,003
-627
-0.9% -$185K 7.68% 1
2022
Q3
$19M Buy
70,630
+4,145
+6% +$1.12M 6.95% 3
2022
Q2
$14.2M Buy
66,485
+14,985
+29% +$3.21M 6.84% 3
2022
Q1
$14.6M Buy
51,500
+245
+0.5% +$69.6K 5.52% 8
2021
Q4
$24.7M Buy
51,255
+340
+0.7% +$164K 6.39% 4
2021
Q3
$26.7M Sell
50,915
-5,465
-10% -$2.86M 7.59% 2
2021
Q2
$25.9M Sell
56,380
-2,750
-5% -$1.26M 7.95% 2
2021
Q1
$17.1M Sell
59,130
-13,470
-19% -$3.9M 6.6% 2
2020
Q4
$18.1M Sell
72,600
-15
-0% -$3.75K 7.05% 2
2020
Q3
$16.4M Buy
72,615
+220
+0.3% +$49.8K 8.08% 1
2020
Q2
$12.6M Buy
72,395
+65
+0.1% +$11.3K 6.76% 6
2020
Q1
$9.13M Buy
72,330
+7,355
+11% +$928K 6.59% 6
2019
Q4
$9.93M Buy
64,975
+51,020
+366% +$7.79M 5.61% 11
2019
Q3
$1.85M Buy
13,955
+7,990
+134% +$1.06M 1.25% 14
2019
Q2
$846K Hold
5,965
0.6% 19
2019
Q1
$866K Hold
5,965
0.68% 16
2018
Q4
$675K Hold
5,965
0.63% 18
2018
Q3
$803K Hold
5,965
0.58% 15
2018
Q2
$670K Buy
5,965
+1,200
+25% +$135K 0.48% 18
2018
Q1
$509K Hold
4,765
0.43% 18
2017
Q4
$522K Buy
+4,765
New +$522K 0.42% 19